Sermo, the physician online community, formally launched its "Discuss on Sermo" initiative, by which journal publishers provide links to articles and research and can facilitate discussions on them among their readers and Sermo members.

There is no point in running a great journal ad if no one notices it. But how do you truly determine if the signal is cutting through the noise? Stephen Hellebusch tests the theory of signal detectability on a group of primary care physicians

Sales reps could be effectively barred from circulating journal article reprints discussing off-label uses under FDA's draft guidance on "good reprint practices," and the agency considers the policy to be effective already, even in its draft form.

The FDA has issued draft guidance on "Good reprint practices" for distribution of journal articles involving unapproved uses of FDA-approved drugs and medical devices.

Ascend Media has sold its struggling medical titles to Intellisphere for an undisclosed sum.

Advanstar Communications unveiled a centralized physician portal for its healthcare group, integrating sites for its five primary care and seven specialty titles into one address, ModernMedicine.com.

The FDA is set to issue draft guidance outlining criteria for dissemination of journal articles on off-label uses, a Congressman has found.

Psychiatrists asked to recall the tenor of discussions they had with industry sales people regarding the newest class of schizophrenia drugs said such conversations tended more toward on-label indications than the off-label kind. Nonetheless, the clinicians' independence may have been compromised, researchers wrote this month in the journal Psychiatric Services, as some reps verbally referred to off-label uses.

Elsevier is upping the ante for online medical publishing with an advertising-supported website for physicians using content from most of its more than 100 oncology titles.

The Association of Medical Media, together with the American Business Media, has launched an ad campaign it hopes will help ease sharp cutbacks in primary care journal advertising.